Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and beauty - Do you regret doing full femtosecond for 300-degree myopia?
Do you regret doing full femtosecond for 300-degree myopia?
No regrets, quick recovery. Aier Eye Hospital Group is a leading ophthalmic medical group in terms of hospital scale and medical capacity in China and even in the world, covering Asia, Europe and North America. It owns three listed companies in China, Europe and Southeast Asia (Shenzhen, China: Aieryan, 300015; Spain; Singapore: 40T). There are more than 700 ophthalmic medical institutions, and the annual outpatient volume in Chinese mainland exceeds100000 person-times. Click on the price consultation of myopia surgery.

Shenzhen Aier Eye Hospital is a professional eye hospital established by Aier Eye Hospital Group in Shenzhen. Committed to providing professional and high-quality ophthalmic medical services for Guangdong-Hong Kong-Macao Greater Bay Area residents, and strive to become a professional ophthalmic hospital integrating medical treatment, scientific research and teaching. We have reached a strategic cooperation and strong alliance with Jinan University, and are committed to building a domestic first-class and internationally renowned ophthalmology Industry-University-Research platform. Trusted by the government and recognized by the people, it has been successively approved as a designated hospital for industrial injury medical insurance, a post-doctoral innovative practice base (municipal level), the first batch of health education bases in Shenzhen, an international orthokeratology association, a member unit of the national professional steering committee, a vice-president unit of the optometry branch of the National Health Planning Commission, and an honest private hospital. Aier Ophthalmology has the following advantages:

1. tertiary eye hospital, IPO listed, with more than 700 global chain institutions.

2. Reach a strategic cooperation and strong alliance with Jinan University, and strive to build a domestic first-class and internationally renowned ophthalmology Industry-University-Research platform.